Life ScienceCompany
Novolytics - Bacteriophage Assets Ownership
Who owns Novolytics - Bacteriophage Assets?
Novolytics - Bacteriophage Assets is owned by Armata Pharmaceuticals. It was acquired on January 8, 2016.
Novolytics - Bacteriophage Assets Business Overview
Where is Novolytics - Bacteriophage Assets headquartered?
Novolytics - Bacteriophage Assets is headquartered in United Kingdom.
What sector is Novolytics - Bacteriophage Assets in?
Novolytics - Bacteriophage Assets is a life science company.
Life Science M&A Summary in 2016
Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.
Join Mergr to view all 295 acquisitions of life science companies in 2016, including 33 acquisitions by private equity firms, and 262 by strategics.